NCT06936072

Brief Summary

To evaluate the efficacy of titanium ring inlay in ESS technique in Temporomandibular joint eminence augmentation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 5, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
Last Updated

April 20, 2025

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

April 5, 2025

Last Update Submit

April 13, 2025

Conditions

Keywords

TMJTMJ augmentationAugmentationOral and Maxillofacial surgery

Outcome Measures

Primary Outcomes (1)

  • Functional improvement

    Measuring the Maximal interincisal opening (MIO; mm)

    Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

Secondary Outcomes (3)

  • Pain Score

    Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

  • Headache

    Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

  • Tinnitus

    Baseline (T0); T1 (1 months postoperative); T2 (3 months postoperative); T3 (6 months postoperative); T4 (12 months postoperative).

Study Arms (1)

Titanium Ring Inlay Eminence Augmentation Group

EXPERIMENTAL

Procedure: Novel titanium ring inlay eminence augmentation via modified ESS technique Inverted L-shaped osteotomy with controlled greenstick fracture Precise titanium ring (12-15mm diameter) implantation Surgical Protocol: * Preauricular approach with subperiosteal dissection * Dual osteotomy (transverse mid-eminence + vertical parallel to skull base) * Titanium ring inlay placement with anatomical contouring * Intraoperative functional assessment Postoperative Care: * Standardized analgesic protocol * Physiotherapy protocol initiation at 2 weeks * Gradual return to function protocol Follow-up Schedule: * Clinical assessments at 5 timepoints (T0-T4) * Standardized outcome measurements (VAS, MIO, etc.) Key Characteristics: Single-arm interventional design All participants receive identical surgical protocol Standardized outcome assessment methodology Blinded evaluators for outcome measures (where applicable) Rationale for Single Arm Design: First-in-human evaluation of nov

Procedure: Titanium Ring Inlay Eminence Augmentation

Interventions

* Preauricular approach with subperiosteal dissection * Dual osteotomy (transverse mid-eminence + vertical parallel to skull base) * Titanium ring inlay placement with anatomical contouring * Intraoperative functional assessment

Titanium Ring Inlay Eminence Augmentation Group

Eligibility Criteria

Age25 Years - 41 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed TMJ dysfunction requiring eminence augmentation
  • Failed conservative management (≥3 months)
  • Adequate bone stock for inlay placement
  • Willingness to comply with follow-up protocol

You may not qualify if:

  • Systemic conditions contraindicating surgery
  • Active TMJ infection
  • Previous TMJ surgery
  • Pregnancy
  • Neuromuscular disorders-

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Menoufia University, Faculty of Medicine, University Hospital

Menoufia University, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A prospective study was conducted on 100 patients (28 males, 72 females; age range: 25-41 years) with TMJ Temporomandibular joint eminence augmentation. Study was performed after ethical approval from Research Ethics Committee, Faculty of Dentistry, Sinai University OMS 01-04-024.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of Oral and Maxillofacial Surgery

Study Record Dates

First Submitted

April 5, 2025

First Posted

April 20, 2025

Study Start

April 28, 2024

Primary Completion

April 3, 2025

Study Completion

April 3, 2025

Last Updated

April 20, 2025

Record last verified: 2025-04

Locations